Why GSK (LON: GSK) and Sanofi's (EPA: SAN) Covid-19 vaccine got dela...

Summary The Covid-19 vaccine jointly developed by Britain’s GSK and France’s Sanofi has been delayed to the end of 2021 Both the pharm...

AstraZeneca (LON: AZN) Vaccine Model Yet to Clear the Doubts of US R...

Summary The executive vice-president at AstraZeneca biopharmaceuticals R&D Sir Menelas Pangalos has expressed his doubts over early FDA approva...

Allergy Therapeutics (LON: AGY) Shareholders Refuse to Pass Crucial...

The fully integrated specialty pharmaceutical group, Allergy Therapeutics PLC has said that all the resolutions which were proposed at its Annual Gene...

Pfizer-BioNTech Covid-19 vaccine ensures ‘overwhelmingly high effica...

Summary US FDA has commended the expeditious response of Pfizer and BioNTech in Covid-19 vaccine development Pfizer-BioNTech co-developed coronavi...

What are the progressive developments made by N4 Pharma in collabora...

Summary N4 Pharma Plc has reported an increase of 5.9% in operating loss during H1 FY20. The Company has started the first phase of research to te...

Pfizer-BioNTech Covid-19 vaccine just few hours away from the UK, sa...

The United Kingdom administration is all set to get the very first doses of the clinically-approved coronavirus vaccine developed by Pfizer-BioNTech m...

Is Covid-19 Vaccine Approval Hasty? FDA Commissioner Defends the Del...

Summary In a first, the UK has swiftly approved the Pfizer-BioNTech developed coronavirus vaccine The drug regulators across various nations inclu...

MHRA approves Pfizer-BioNTech vaccine for the UK, will be available...

In a historic development, the Medicines and Healthcare Products Regulatory Authority (MHRA) of the United Kingdom has given approval to the Pfizer-Bi...

AstraZeneca PLC (LON: AZN) to Sell the rights of Crestor, related me...

AstraZeneca PLC (LON: AZN) will be selling its rights of Crestor and some related medicines to Germany-based Grünenthal GmbH in more than 30 coun...

Why Indivior (LON: INDV) shares suffered a 20%-crash on Friday

Shares of Indivior, the Chesterfield-headquartered pharmaceuticals company, crashed nearly 20 per cent at the close of the trading window on Friday, 2...

Pharma Stocks in Focus: Novartis (NYSE: NVS), Intercept Pharmaceutic...

The pharmaceuticals industry has also been gripped by the aftereffects of coronavirus pandemic as even the pharma shares representing some of the majo...

COVID-19: AstraZeneca-Oxford’s Vaccine Shows 70 Per Cent Efficiency...

Summary AstraZeneca said the Covid-19 vaccination, which the firm has been developing along with Oxford University, has shown a 70 per cent efficac...

Pfizer Covid-19 Vaccine Is World's First To Seek Emergency US Approv...

  Pfizer and its partner BioNTech have submitted their report seeking early approvals from FDA for its Covid-19 vaccine The company has also...

Pfizer-BioNTech vaccine to face stiff competition despite high succe...

Summary The vaccine candidate was found to be 90 per cent efficient in preventing Covid-19 infection, making it one of the most effective against t...

Pfizer and BioNTech Skyrocket on Covid-19 Vaccine Results

Stock markets across the world witnessed a sharp uptick on Monday after initial data of a clinical trial showed that Pfizer and BioNTech’s vacci...

Arix Bioscience plc’s VelosBio to be acquired by Merck

Summary NYSE listed Merck acquired VelosBio, a portfolio company of Arix Bioscience for US$2.75 billion Arix’s investment in VelosBio grew b...

TFF Pharmaceuticals releases results for Q3 2020

Summary TFF Pharmaceuticals Inc. was incorporated in 2018 as a clinical-stage biopharmaceutical company The company’s patented technology pl...

How are these two AIM stocks performing: LiDCO Group Plc and TomCo E...

Summary LiDCO Group Plc witnessed sales growth of 75% year-on-year during H1 FY21. The Company is getting acquired by Masimo Corporation. TomCo E...

AstraZeneca’s Potential Covid-19 Vaccine Goes Under Accelerated Revi...

Summary The UK’s Medicines and Healthcare Products Regulatory Agency has started the rolling review of AstraZeneca’s potential Covid- 1...

Performance Review of Two Stocks Trending on the LSE: GlaxoSmithKlin...

Summary GlaxoSmithKline Plc reported a revenue decline of 8% for Q3 FY20 The Company partnered with COVAX to provide 200 million doses of Covid-19...